Aukerman; Sharon Lea

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aukerman; Sharon Lea.The latest application filed is for "uses of anti-cd40 antibodies".

Company Profile

0.4.10

Aukerman; Sharon Lea - Mosaga CA
Aukerman; Sharon Lea - Moraga CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Anti-cd40 Antibodies App 20150086991 - Aukerman; Sharon Lea ; et al.	2015-03-26
Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies Grant 8,926,979 - Aukerman , et al. January 6, 2	2015-01-06
Methods For Diagnosis And Treatment Of Proliferative Disorders Mediated By Cd40 Signaling App 20130230528 - Aukerman; Sharon Lea ; et al.	2013-09-05
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use App 20130011405 - Long; Li ; et al.	2013-01-10
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer Grant 8,337,851 - Aukerman , et al. December 25, 2	2012-12-25
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease Grant 8,333,970 - Aukerman , et al. December 18, 2	2012-12-18
Small animal model for hcv replication App 20100017895 - Weiner; Amy ; et al.	2010-01-21
Uses Of Anti-cd40 Antibodies App 20090202531 - Aukerman; Sharon Lea ; et al.	2009-08-13
Uses Of Anti-cd40 Antibodies App 20090117111 - Aukerman; Sharon Lea ; et al.	2009-05-07
Methods For Diagnosis And Treatment Of Proliferative Disorders Mediated By Cd40 Signaling App 20090041773 - Aukerman; Sharon Lea ; et al.	2009-02-12
Methods for Diagnosis and Treatment of Diseases Having an Autoimmune and/or Inflammatory Component App 20080274118 - Aukerman; Sharon Lea ; et al.	2008-11-06
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use App 20080254026 - Long; Li ; et al.	2008-10-16
Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia App 20070110754 - Long; Li ; et al.	2007-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.